Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,917 | -25,279 | -163,415 | -127,756 | -104,168 |
| Depreciation Amortization | 12,339 | 6,078 | 11,946 | 6,053 | 2,980 |
| Accounts receivable | 7,538 | 12,969 | -43,974 | -23,840 | -11,332 |
| Other Working Capital | 25,505 | 23,942 | -19,221 | -11,774 | -6,131 |
| Other Operating Activity | 15,944 | -2,498 | 143,720 | 102,991 | 82,546 |
| Operating Cash Flow | $11,409 | $15,212 | $-70,944 | $-54,326 | $-36,105 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -61,938 | 0 | 125,671 | 122,671 | 92,671 |
| PPE Investments | -792 | -13 | -109 | -109 | -109 |
| Net Acquisitions | N/A | N/A | -212,762 | -212,762 | N/A |
| Purchase Sale Intangibles | -10,000 | N/A | -20,000 | -15,000 | -15,000 |
| Other Investing Activity | -10,000 | 0 | -20,000 | -15,000 | -15,000 |
| Investing Cash Flow | $-72,730 | $-13 | $-107,200 | $-105,200 | $77,562 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 305,304 | 305,304 | 305,304 |
| Common Stock Issued | 8,496 | 1,205 | 227,154 | 225,096 | 17,967 |
| Other Financing Activity | 0 | 0 | -195,858 | -195,577 | -195,577 |
| Financing Cash Flow | $8,496 | $1,205 | $336,600 | $334,823 | $127,694 |
| Exchange Rate Effect | -6 | 113 | -133 | -241 | 74 |
| Beginning Cash Position | 286,326 | 286,326 | 128,003 | 128,003 | 128,003 |
| End Cash Position | 233,495 | 302,843 | 286,326 | 303,059 | 297,228 |
| Net Cash Flow | $-52,831 | $16,517 | $158,323 | $175,056 | $169,225 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,409 | 15,212 | -70,944 | -54,326 | -36,105 |
| Capital Expenditure | -792 | -13 | -109 | -109 | -109 |
| Free Cash Flow | 10,617 | 15,199 | -71,053 | -54,435 | -36,214 |